Evidence map›Paper›PMID 33257668›Full record

ArticleNature communications2020

Location-specific inhibition of Akt reveals regulation of mTORC1 activity in the nucleus.

Xin Zhou, Yanghao Zhong, Olivia Molinar-Inglis, Maya T Kunkel, Mingyuan Chen, Tengqian Sun, Jiao Zhang, John Y-J Shyy, JoAnn Trejo, Alexandra C Newton and 1 more

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed
1.9field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 49 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Zinc Alleviates Gut Barrier Dysfunction by Promoting the Methylation of AKT.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025
    Article
  8. Conformation-specific synthetic intrabodies modulate mTOR signaling with subcellular spatial resolution.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Review
  15. Article
  16. Review
  17. Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 1 institution in 1 country.

Xin ZhouDepartment of Pharmacology, University of California, San Diego, La Jolla, CA, USA.ORCID 0000-0003-0734-0828
Yanghao ZhongDepartment of Pharmacology, University of California, San Diego, La Jolla, CA, USA.
Olivia Molinar-InglisDepartment of Pharmacology, University of California, San Diego, La Jolla, CA, USA.
Maya T KunkelDepartment of Pharmacology, University of California, San Diego, La Jolla, CA, USA.ORCID 0000-0002-0027-5149
Mingyuan ChenDepartment of Bioengineering, University of California, San Diego, La Jolla, CA, USA.
Tengqian SunDepartment of Pharmacology, University of California, San Diego, La Jolla, CA, USA.
Jiao ZhangDivision of Cardiology, Department of Medicine, University of California San Diego, La Jolla, CA, USA.
John Y-J ShyyDivision of Cardiology, Department of Medicine, University of California San Diego, La Jolla, CA, USA.ORCID 0000-0002-5625-753X
JoAnn TrejoDepartment of Pharmacology, University of California, San Diego, La Jolla, CA, USA.
Alexandra C NewtonDepartment of Pharmacology, University of California, San Diego, La Jolla, CA, USA.
Jin ZhangDepartment of Pharmacology, University of California, San Diego, La Jolla, CA, USA. jzhang32@ucsd.edu.ORCID 0000-0001-7145-7823
University of California San Diego · US

Funding

VIRAL MALIGNANCYP30CA023100 · NCI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI Jesse Nodora · 1985 to 2026
$124.9M
UCSD/SDSU IRACDAK12GM068524 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI TREJO, JOANN · 2003 to 2025
$24.4M
Live-cell Activity Architecture in CancerR35CA197622 · NCI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI Jin Zhang · 2015 to 2026
$11.2M
U of Calif, San Diego Neuroscience Microscopy ImagingP30NS047101 · NINDS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI GLEESON, JOSEPH G, ZHENG, BINHAI · 2003 to 2022
$9.0M
Molecular Mechanisms of Cell SignalingR35GM122523 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI ALEXANDRA C. NEWTON · 2017 to 2026
$6.7M
Cell Signaling by Protease-activated G Protein-coupled ReceptorsR35GM127121 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI Joann Trejo · 2018 to 2026
$4.5M
Signal Transduction by PI3K/Akt/mTOR PathwayR01GM111665 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI ZHANG, JIN · 2015 to 2018
$1.2M
NCI NIH HHS P30 CA023100NCI NIH HHS R35 CA197622NIGMS NIH HHS K12 GM068524NIGMS NIH HHS R01 GM111665NIGMS NIH HHS R35 GM122523NIGMS NIH HHS R35 GM127121NINDS NIH HHS P30 NS047101
6 · The paper itself

Abstract

The mechanistic target of rapamycin complex 1 (mTORC1) integrates growth, nutrient and energy status cues to control cell growth and metabolism. While mTORC1 activation at the lysosome is well characterized, it is not clear how this complex is regulated at other subcellular locations. Here, we combine location-selective kinase inhibition, live-cell imaging and biochemical assays to probe the regulation of growth factor-induced mTORC1 activity in the nucleus. Using a nuclear targeted Akt Substrate-based Tandem Occupancy Peptide Sponge (Akt-STOPS) that we developed for specific inhibition of Akt, a critical upstream kinase, we show that growth factor-stimulated nuclear mTORC1 activity requires nuclear Akt activity. Further mechanistic dissection suggests that nuclear Akt activity mediates growth factor-induced nuclear translocation of Raptor, a regulatory scaffolding component in mTORC1, and localization of Raptor to the nucleus results in nuclear mTORC1 activity in the absence of growth factor stimulation. Taken together, these results reveal a mode of regulation of mTORC1 that is distinct from its lysosomal activation, which controls mTORC1 activity in the nuclear compartment.

Indexed as

AnimalsCell NucleusGene Knockdown TechniquesHEK293 CellsHumansMechanistic Target of Rapamycin Complex 1MiceNIH 3T3 CellsPhosphoproteinsProtein Kinase InhibitorsProto-Oncogene Proteins c-aktSignal TransductionTOR Serine-Threonine KinasesMechanistic Target of Rapamycin Complex 1Phosphoproteinsproline-rich Akt substrate, 40 kDa protein, mouseProtein Kinase InhibitorsProto-Oncogene Proteins c-aktTOR Serine-Threonine Kinases

Identifiers

PMID33257668
PMCPMC7705703
OpenAlexW3107255157

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.